Emily Feneberg
Technische Universität München
H-index: 19
Europe-Germany
Top articles of Emily Feneberg
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Smell the smoke before one sees the fire-The oligosymptomatic prodromal phase of neurodegenerative diseases | Andreas Wolff Antonia Franziska Demleitner Emily Feneberg Paul Lingor | 2024/4/17 | |
Den Rauch riechen, bevor man das Feuer sieht–die oligosymptomatische Prodromalphase neurodegenerativer Erkrankungen | Andreas Wolff Antonia Franziska Demleitner Emily Feneberg Paul Lingor | 2024/4/17 | |
A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors | Imogen J Swift Rosa Rademakers NiCole Finch Matt Baker Roberta Ghidoni | 2024/3/28 | |
Atypical TDP‐43 protein expression in an ALS pedigree carrying a p.Y374X truncation mutation in TARDBP | Brain Pathology | Johnathan Cooper‐Knock Thomas H Julian Emily Feneberg J Robin Highley Maurice Sidra | 2023/1 |
Advantages of routine next‐generation sequencing over standard genetic testing in the amyotrophic lateral sclerosis clinic | European Journal of Neurology | Jakub Scaber Alexander G Thompson Lucy Farrimond Emily Feneberg Malcolm Proudfoot | 2023/8 |
Parkinson’s disease therapy: what lies ahead? | Andreas Wolff Nicolas U Schumacher Dominik Pürner Gerrit Machetanz Antonia F Demleitner | 2023/6 | |
TDP-43 proteinopathy specific biomarker development | Isabell Cordts Annika Wachinger Carlo Scialo Paul Lingor Magdalini Polymenidou | 2023/2/12 | |
SARS-CoV-2 and neurodegenerative diseases: What we know and what we don’t | Paul Lingor Antonia F Demleitner Andreas W Wolff Emily Feneberg | 2022/9 | |
Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain | Brain communications | Alexander G Thompson Elizabeth Gray Nick Verber Yoana Bobeva Vittoria Lombardi | 2022/2/1 |
BRAIN COMMUNICATIONS AIN COMMUNICATIONS | LA Benjamin E Lim M Sokolska J Markus T Zaletel | 2022 | |
Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS | Journal of Neurology, Neurosurgery & Psychiatry | Steffen Halbgebauer Petra Steinacker Federico Verde Jochen Weishaupt Patrick Oeckl | 2022/1/1 |
Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis | Alexander G Thompson Patrick Oeckl Emily Feneberg Robert Bowser Markus Otto | 2021/11/2 | |
Detection and quantification of novel C‐terminal TDP‐43 fragments in ALS‐TDP | Brain Pathology | Emily Feneberg Philip D Charles Mattéa J Finelli Connor Scott Benedikt M Kessler | 2021/7 |
Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study | Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | Petra Steinacker Emily Feneberg Steffen Halbgebauer Simon Witzel Federico Verde | 2021/4/3 |
Gene-specific treatment approaches in Alzheimer’s disease and other tauopathies | E Feneberg M Otto | 2020/4 | |
Genspezifische Therapieansätze bei der Alzheimer-Krankheit und anderen Tauopathien [Gene-specific treatment approaches in Alzheimer's disease and other tauopathies] | Der Nervenarzt | E Feneberg M Otto | 2020/2/19 |
An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress | Neurobiology of disease | Emily Feneberg David Gordon Alexander G Thompson Mattéa J Finelli Ruxandra Dafinca | 2020/10/1 |
Amyotrophic lateral sclerosis with a heterozygous D91A SOD1 variant and classical ALS-TDP neuropathology | Neurology | Emily Feneberg Martin R Turner Olaf Ansorge Kevin Talbot | 2020/9/29 |
